The Study On Analysis Of The Performance Of Industrial Chain Extension In Fosun Pharma

With the rapid development of China's economy,people's quality of life has been continuously improved,and the emphasis on medical health has been continuously increased.Medical and health expenditure has increased year by year,and China's pharmaceutical market has maintained rapid growth.However,due to the immature industry system,insufficient R&D innovation capability,and lack of vitality in the market structure,compared with developed countries,China's pharmaceutical industry has obvious competitive disadvantages.In the face of industry development bottlenecks and shrinking profit margins,enterprises have adopted The extension of the industrial chain,enhanced cost control and competitive advantage,and the right to market discourse,the decision-making changes in the implementation of the strategy and market layout of the company have a direct impact on the development of the pharmaceutical industry.Therefore,this paper analyzes the extension path and method from the strategic perspective of the industrial chain extension of the pharmaceutical manufacturing industry and discusses the internal relationship between the extension of the industry chain and the performance of the business.Starting from the background of the pharmaceutical manufacturing industry,this paper focuses on the extension of the industrial chain,selects the representative enterprise Fosun Pharma,and explores the basic support,implementation path and impact on the performance of the industry chain.First of all,based on the concept definition,theoretical basis and literature review,this paper analyzes the current problems faced by the pharmaceutical industry,the driving factors of the extension and the impact mechanism on the performance.Secondly,the case study of Fosun Pharma is selected to analyze the motivation,basis and path of the implementation of the industrial chain extension strategy.Finally,from the short-term performance and financial performance of the market,it analyzes the dynamic changes of the business operation under the industry chain extension strategy.The short-term performance mainly analyzes the stock price performance of major events in the industry chain extension,and the financial performance focuses on analyzing the enterprise itself.The analysis of changes in operating conditions is carried out in five dimensions:profitability,operational capability,solvency,development capability and cash ability.On the whole,Fosun Pharma has implemented its industrial chain extension strategy,broadened its business scope,expanded its production and operation scale,avoided trading risks,realized the competitive advantages of the entire industry chain in the upper,middle and lower reaches,enhanced its profitability,and ultimately improved its comprehensive strength.And Fosun Pharma has shown a strong development momentum and gained the horsepower for the industry's leading position.Under the current severe situation of China's pharmaceutical industry,the research conclusions of this paper have important practical implications for the pharmaceutical manufacturers to achieve leap-forward development and stimulate innovation potential.